/
Infectious Disease
736Diseases↗
7.6KPipeline Programs↗
1.9KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
13,345
clinical trials
Completed7,853 · 59%
Unknown status1,811 · 14%
Terminated1,085 · 8%
Recruiting928 · 7%
Withdrawn530 · 4%
Not yet recruiting501 · 4%
Other637 · 5%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
Landscape
Diseases
COVID-19
Most programs1,444
Programs
160
Trials
55
Recruiting
Pre
293
P1
248
P2
666
P3
535
Appr
206
Most programs:
Pfizer
PfizerInfluenza
Most trials684
Programs
101
Trials
37
Recruiting
Pre
82
P1
236
P2
334
P3
241
Appr
190
Most programs:
GSK
GSKChronic Hepatitis
Highest activity483
Programs
97
Trials
24
Recruiting
Pre
70
P1
84
P2
217
P3
128
Appr
130
Most programs:
Gilead
GileadPneumonia
2423 programs91 trialsApproved
Malaria
5359 programs55 trialsApproved
Hepatitis
1184 programs206 trialsApproved
HIV
2112 programs310 trialsApproved
Sepsis
6232 programs75 trialsApproved
Hepatitis B
2167 programs128 trialsApproved
HIV Infection
3282 programs12 trialsApproved
Tuberculosis
6216 programs69 trialsApproved
Hepatitis C
1248 programs11 trialsApproved
Septic Shock
2161 programs43 trialsApproved
COVID
0 programs192 trialsPhase 3
Urinary Tract Infection
1129 programs28 trialsApproved
HPV
10 programs156 trialsApproved
HIV-1 Infection
4124 programs11 trialsApproved
Pulmonary Tuberculosis
97 programs14 trialsApproved
Herpes Zoster
60 programs39 trialsApproved
Chronic Hepatitis B Virus Infection
72 programs13 trialsApproved
Chronic Hepatitis B
0 programs84 trialsApproved
Respiratory Tract Infection
166 programs11 trialsApproved
Meningioma
347 programs27 trialsApproved
Abscess
53 programs19 trialsApproved
HIV-1
10 programs70 trialsPhase 1
Hepatitis C Virus Infection
67 programs1 trialApproved
Chronic Hepatitis C Virus Infection
67 programs1 trialApproved
Plasmodium Falciparum Malaria
65 programs1 trialApproved
Osteomyelitis
60 programs6 trialsApproved
EBV
10 programs63 trialsPhase 1
Showing top 30 diseases by activity. 706 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)